Predictors of Lumpectomy Size after Breast-Conserving Surgery in Patients with Breast Cancer: A Retrospective Cohort Study

被引:0
|
作者
Makineli, Seher [1 ]
Strijbis, Rogier [2 ]
Tsehaie, Jonathan [2 ]
Schellekens, Pascal P. A. [2 ]
Moman, Maaike R. [3 ]
Veenendaal, Liesbeth M. [4 ]
Ferdinandus, Patrick I. [5 ]
Witkamp, Arjen J. [1 ]
Richir, Milan C. [1 ]
Maarse, Wies [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Gen Surg, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[4] Alexander Monro Hosp, Dept Gen Surg, Bilthoven, Netherlands
[5] Alexander Monro Hosp, Dept Plast Reconstruct & Hand Surg, Bilthoven, Netherlands
关键词
20-YEAR FOLLOW-UP; MASTECTOMY; TRIAL;
D O I
10.1097/PRS.0000000000011085
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Oncoplastic reconstructive surgery as an extension of breast-conserving surgery leads to better aesthetic results, an increase in tumor-free margins, and a reduction in reexcision rates. Oncologic resection is often more extensive than expected, sometimes resulting in the plastic surgeon deviating from the predetermined plan. For optimal planning of the reconstruction, it is mandatory to estimate volume defects after lumpectomy as accurately as possible. The authors aimed to identify preoperative predictors of lumpectomy resection size. Methods: All consecutive patients diagnosed with invasive breast carcinoma or carcinoma in situ and treated primarily with breast-conserving surgery between 2018 and 2020 at the University Medical Center Utrecht or Alexander Monro Hospital were included. Patient and tumor characteristics were measured. Data were analyzed in a multiple linear regression analysis. Results: A total of 410 patients (423 cases) were included, with a median age of 58 years (range, 32 to 84 years) and a mean body mass index (BMI) of 25.0 (SD 9.3). The mean maximum radiologic tumor diameter was 18.0 mm (SD 13.2), and the mean maximum lumpectomy diameter was 58.8 mm (SD 19.2). Multiple linear regression analysis found an explained variance of R2 = 0.60 (P < 0.00), corrected for operating surgeon. Significant predictors for postoperative lumpectomy size were BMI, breast size, and maximum preoperative radiologic tumor diameter. A predictive tool for lumpectomy size was developed and a web-based application created to facilitate use of the tool in a clinical setting. Conclusions: Postoperative lumpectomy size can be predicted using BMI, breast size, and radiologic tumor size. This model could be beneficial for breast surgeons in planning reconstructions and preparing and informing their patients more accurately.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 50 条
  • [41] Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis
    Chen, Jun-Ying
    Huang, Yi-Jie
    Zhang, Liu-Lu
    Yang, Ci-Qiu
    Wang, Kun
    JOURNAL OF BREAST CANCER, 2018, 21 (03) : 321 - +
  • [42] Radiotherapy after breast-conserving surgery for elderly patients with early-stage breast cancer: A national registry-based study
    Wang, Fei
    Meszoely, Ingrid
    Pal, Tuya
    Mayer, Ingrid A.
    Bailey, Christina E.
    Zheng, Wei
    Shu, Xiao-Ou
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (04) : 857 - 867
  • [43] Trends and survival benefits of bilateral breast-conserving surgery in patients with metachronous bilateral breast cancer
    Huang, Qiuyan
    Lin, Qingzhong
    Yang, Yinlong
    BMC WOMENS HEALTH, 2025, 25 (01)
  • [44] Waiting time for radiation therapy after breast-conserving surgery in early breast cancer: a retrospective analysis of local relapse and distant metastases in 615 patients
    Caponio, Raffaella
    Ciliberti, Maria Paola
    Graziano, Giusi
    Necchia, Rocco
    Scognamillo, Giovanni
    Pascali, Antonio
    Bonaduce, Sabino
    Milella, Anna
    Matichecchia, Gabriele
    Cristofaro, Cristian
    Di Fatta, Davide
    Tamborra, Pasquale
    Lioce, Marco
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2016, 21
  • [45] The Effect of Lumpectomy and Cavity Shave Margin Status on Recurrence and Survival in Breast-Conserving Surgery
    Abdelsattar, Jad M.
    Afridi, Faryal G.
    Dai, Zheng
    Yousaf, Natasha
    Seldomridge, Ashlee
    Battin, Alexander O.
    Wen, Sijin
    Gray, Dana
    Marsh, J. Wallis
    Cowher, Michael S.
    Partin, Jessica F.
    Hazard-Jenkins, Hannah
    Lupinacci, Kristin
    AMERICAN SURGEON, 2023, 89 (03) : 424 - 433
  • [46] A Novel Inclusion Criteria for Radiotherapy Omission in Elderly Breast Cancer Patients with Breast-Conserving Surgery
    Heng, Y. L.
    Xiao, J.
    Liu, L. Q.
    Luo, J.
    Luo, J.
    Chen, J.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2024, 27 (12) : 1417 - 1428
  • [47] Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients
    Shin, Hee-Chul
    Han, Wonshik
    Moon, Hyeong-Gon
    Im, Seock-Ah
    Moon, Woo Kyung
    Park, In-Ae
    Park, Sung Jun
    Noh, Dong-Young
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) : 2582 - 2589
  • [48] The Postoperative Breast: Imaging Findings and Diagnostic Pitfalls After Breast-Conserving Surgery and Oncoplastic Breast Surgery
    Pittman, Sarah M.
    Rosen, Eric L.
    DeMartini, Wendy B.
    Nguyen, Dung H.
    Poplack, Steven P.
    Ikeda, Debra M.
    JOURNAL OF BREAST IMAGING, 2024, 6 (02) : 203 - 216
  • [49] Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis
    Chen, Si-Ye
    Tang, Yu
    Wang, Shu-Lian
    Song, Yong-Wen
    Fang, Hui
    Wang, Jian-Yang
    Jing, Hao
    Zhang, Jiang-Hu
    Sun, Guang-Yi
    Zhao, Xu-Ran
    Jin, Jing
    Liu, Yue-Ping
    Chen, Bo
    Qi, Shu-Nan
    Li, Ning
    Tang, Yuan
    Lu, Ning-Ning
    Ren, Hua
    Yu, Zi-Hao
    Li, Ye-Xiong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
    Chen, Kunzhi
    Sun, Wuji
    Han, Tao
    Yan, Lei
    Sun, Minghui
    Xia, Wenming
    Wang, Libo
    Shi, Yinghua
    Ge, Chao
    Yang, Xu
    Li, Yu
    Wang, Huidong
    FRONTIERS IN ONCOLOGY, 2023, 13